ID   TASK1
AC   CVCL_3177
DR   CLO; CLO_0037092
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470806
DR   cancercelllines; CVCL_3177
DR   Cell_Model_Passport; SIDM00026
DR   Cosmic-CLP; 1299067
DR   DepMap; ACH-001670
DR   EGA; EGAS00001000978
DR   GDSC; 1299067
DR   GEO; GSM827197
DR   GEO; GSM1670524
DR   JCRB; JCRB0139
DR   JCRB; NIHS0202
DR   LINCS_LDP; LCL-1114
DR   PharmacoDB; TASK1_1565_2019
DR   Progenetix; CVCL_3177
DR   Wikidata; Q54971734
RX   PubMed=9661044;
RX   PubMed=20215515;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 38 hours (PubMed=9661044).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=9661044).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Genome ancestry: African=1.94%; Native American=0.97%; East Asian, North=86.4%; East Asian, South=7.58%; South Asian=0.24%; European, North=0%; European, South=2.87% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0202; true.
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
ST   Source(s): Cosmic-CLP=1299067; DepMap=ACH-001670; JCRB=JCRB0139
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30,31
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 30
//
RX   PubMed=9661044; DOI=10.1007/s11626-998-0074-1;
RA   Horiguchi H., Matsui M., Ohtsubo R., Ogata T., Kaneko M., Fujiwara M.,
RA   Kamma H.;
RT   "Establishment and characterization of a typical primitive
RT   neuroectodermal tumor cell line.";
RL   In Vitro Cell. Dev. Biol. Anim. 34:439-442(1998).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//